CompletedNot Applicable

Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage

Finland2,341 participantsStarted 2011-04

Plain-language summary

The purpose of this study is to assess the indirect effects of a pneumococcal conjugate vaccine administered to infants on vaccinees' elder non-vaccinated siblings aged 3 to 7 years.

Who can participate

Age range3 Years – 7 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age 3 to 7 years * younger sibling at least 12 months of age living in the same household participates in the FinIP or 053 trial (regardless of the vaccination schedule) * at least one parent with fluent Finnish * informed consent from one parent Exclusion Criteria: * commercial PCV vaccination administered * study-related PCV vaccination administered (open or blind) * history of antimicrobial treatment within 4 weeks (the child can be enrolled later)

What they're measuring

Carriage Due to Any Pneumococcal Serotype Included in the Ten-valent Pneumococcal Conjugate Vaccine (PCV10) Vaccine in Older Siblings of Children Vaccinated With Infant Schedules

Timeframe: one sampling at 3 to 7 years of age

Trial details

NCT IDNCT01311024

SponsorArto Palmu

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2013-06

Results submitted2014-04-02

View on ClinicalTrials.gov More Pneumococcal Infections trials